former novartis exec to lead cambridge diabetes startup semma.we're an independent, student-run newsroom..
november 14, 2017.copyright © 2018 the daily californian, the independent berkeley student publishing co., inc..it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.